Copyright
©The Author(s) 2021.
World J Gastrointest Endosc. Jul 16, 2021; 13(7): 210-220
Published online Jul 16, 2021. doi: 10.4253/wjge.v13.i7.210
Published online Jul 16, 2021. doi: 10.4253/wjge.v13.i7.210
Drug | Onset of effect (min) | Effect duration (min) | Usual dose | Adverse events |
Benzodiazepines | ||||
Midazolam | 1-2 | 15-80 | 1-6 mg | Respiratory depression, disinhibition |
Flumazenil (Benzodiazepines Antidote) | 1-2 | 60 | 0.1-1 mg | Agitation, withdrawal symptoms |
Opioids | ||||
Alfentanyl | < 1 | 30-60 | 0.250-2 mg | Respiratory and cardiovascular depression |
Fentanyl | 1-2 | 30-60 | 50-200 μg | Respiratory depression, vomiting |
Pethidine | 3-6 | 60-180 | 25-100 mg | Respiratory depression, vomiting |
Naloxone (Opioids antidote) | 1-2 | 30-45 | 0.2-1 mg | Narcotic withdrawal |
Anestethic | ||||
Propofol | < 1 | 4-8 | 40-400 mg | Respiratory and cardiovascular depression |
- Citation: Grassi G, Lenci I, Signorello A, Milana M, Baiocchi L. Gastrointestinal endoscopy in cirrhotic patient: Issues on the table. World J Gastrointest Endosc 2021; 13(7): 210-220
- URL: https://www.wjgnet.com/1948-5190/full/v13/i7/210.htm
- DOI: https://dx.doi.org/10.4253/wjge.v13.i7.210